QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=A801563F123D4A06FFAE7EB888B29FF2;jsessionid=31CEFB16DC4ACEFD18B33830B5B06E06;jsessionid=2508A731CDD4A5B5E1FD1FC85C41824D;jsessionid=0D3B0D90430A87885BC96602F73A76BB;jsessionid=F84531DB79E28AE9DCA47005D038B515;jsessionid=17DD7D3FAE197024493CB00EDACBD853;jsessionid=C42D60E1F1F32AF479F6780D99856399;jsessionid=3D7A31C8DBDCD6D548B7A3BB4EAEBD86 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=A801563F123D4A06FFAE7EB888B29FF2;jsessionid=31CEFB16DC4ACEFD18B33830B5B06E06;jsessionid=2508A731CDD4A5B5E1FD1FC85C41824D;jsessionid=0D3B0D90430A87885BC96602F73A76BB;jsessionid=F84531DB79E28AE9DCA47005D038B515;jsessionid=17DD7D3FAE197024493CB00EDACBD853;jsessionid=C42D60E1F1F32AF479F6780D99856399;jsessionid=3D7A31C8DBDCD6D548B7A3BB4EAEBD86